Literature DB >> 11721971

Human herpes virus 8-negative primary effusion lymphoma in a patient with a ventriculoperitoneal shunt tube.

E Ashihara1, C Shimazaki, H Hirai, T Inaba, G Hasegawa, S Mori, M Nakagawa.   

Abstract

A 60-year-old woman was referred to our hospital in 1996 due to an abdominal distension in the right lower quadrant. She had undergone a partial resection of a cholesteatoma at the right temporal lobe of the cerebrum 30 years previously, and a ventriculoperitoneal shunt (VPS) tube had been placed with drainage into the right lower peritoneal cavity. The patient developed paralytic ileus in December 1966, and ultrasound and computed tomography of the abdomen revealed a cystic mass in the right lower quadrant without lymphadenopathies or masses. Cytologic examinations of the fluid in the cystic mass revealed signs of malignant lymphoma. After the resection of the cystic mass, lymphoma cells were detected in the fluid, but the wall of the cyst consisted of only fibrous tissues. Results of immunophenotypic analysis of the lymphoma cells by immunocytochemistry or flow cytometry were positive for CD19, CD20, CD22, CD45, and HLA-DR but negative for CD45RO, CD3, CD4, and CD8. The genome of human herpes virus (HHV)-8 was not detected in the lymphoma cells, but Epstein-Barr (EB) nuclear antigen 1 and EB virus (EBV)-encoded small nuclear RNAs were detected. Chromosome analysis by the G-banding method showed complicated abnormalities including der(8)t(2;8)(q31;q24), but Southern blotting analysis suggested that the c-myc oncogene did not participate in the lymphomagenesis. The patient's disease was diagnosed as HHV-8-negative primary effusion lymphoma (PEL). The long-standing inflammatory stimulation by a VPS tube might have contributed to the clonal evolution of EBV-infected lymphocytes. resulting in the development of PEL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11721971     DOI: 10.1007/bf02982069

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  24 in total

1.  Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.

Authors:  R G Nador; E Cesarman; A Chadburn; D B Dawson; M Q Ansari; J Sald; D M Knowles
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

Review 2.  Herpes virus type 8-negative primary effusion lymphoma associated with PAX-5 gene rearrangement and hepatitis C virus: a case report and review of the literature.

Authors:  R Ichinohasama; I Miura; N Kobayashi; Y Saitoh; J F DeCoteau; Y Saiki; S Mori; M E Kadin; K Ooya
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

3.  Molecular characterization of HHV-8 positive primary effusion lymphoma reveals pathogenetic and histogenetic features of the disease.

Authors:  G Gaidano; D Capello; L Fassone; A Gloghini; A M Cilia; C Ariatti; D Buonaiuto; D Vivenza; M Gallicchio; G C Avanzi; M Prat; A Carbone
Journal:  J Clin Virol       Date:  2000-05       Impact factor: 3.168

4.  Combined spectral karyotyping and DAPI banding analysis of chromosome abnormalities in myelodysplastic syndrome.

Authors:  N Kakazu; M Taniwaki; S Horiike; K Nishida; T Tatekawa; M Nagai; T Takahashi; T Akaogi; J Inazawa; M Ohki; T Abe
Journal:  Genes Chromosomes Cancer       Date:  1999-12       Impact factor: 5.006

5.  Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasms.

Authors:  H Hirai; E Satoh; M Osawa; T Inaba; C Shimazaki; S Kinoshita; M Nakagawa; O Mazda; J Imanishi
Journal:  Biochem Biophys Res Commun       Date:  1997-12-08       Impact factor: 3.575

6.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

Review 7.  Body-cavity-based lymphoma in an elderly AIDS-unrelated male.

Authors:  T Okada; H Katano; H Tsutsumi; T Kumakawa; M Sawabe; T Arai; S Mori; M Mori
Journal:  Int J Hematol       Date:  1998-06       Impact factor: 2.490

8.  Posttransplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus.

Authors:  D Frank; E Cesarman; Y F Liu; R E Michler; D M Knowles
Journal:  Blood       Date:  1995-03-01       Impact factor: 22.113

9.  Distinct biology of Kaposi's sarcoma-associated herpesvirus from primary lesions and body cavity lymphomas.

Authors:  J Friborg; W P Kong; C C Flowers; S L Flowers; Y Sun; K E Foreman; B J Nickoloff; G J Nabel
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Summary of clinical and pathological findings in thirty-seven cases.

Authors:  K Iuchi; K Aozasa; S Yamamoto; T Mori; K Tajima; K Minato; K Mukai; H Komatsu; T Tagaki; Y Kobashi
Journal:  Jpn J Clin Oncol       Date:  1989-09       Impact factor: 3.019

View more
  10 in total

1.  CD5+ diffuse large B-cell lymphoma with c-myc/IgH rearrangement presenting as primary effusion lymphoma.

Authors:  Shinya Fujisawa; Fumihiko Tanioka; Toshihiko Matsuoka; Takachika Ozawa
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

Review 2.  Human herpesvirus 8-negative effusion-based large B-cell lymphoma: a distinct entity with unique clinicopathologic characteristics.

Authors:  Savanah D Gisriel; Ji Yuan; Ryan C Braunberger; Danielle L V Maracaja; Xueyan Chen; Xiaojun Wu; Jenna McCracken; Mingyi Chen; Yi Xie; Laura E Brown; Peng Li; Yi Zhou; Tarsheen Sethi; Austin McHenry; Ronald G Hauser; Nathan Paulson; Haiming Tang; Eric D Hsi; Endi Wang; Qian-Yun Zhang; Ken H Young; Mina L Xu; Zenggang Pan
Journal:  Mod Pathol       Date:  2022-05-13       Impact factor: 8.209

3.  Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis.

Authors:  Daisuke Kaji; Yasunori Ota; Yasuharu Sato; Koji Nagafuji; Yasunori Ueda; Masataka Okamoto; Yasushi Terasaki; Naoko Tsuyama; Kosei Matsue; Tomohiro Kinoshita; Go Yamamoto; Shuichi Taniguchi; Shigeru Chiba; Koichi Ohshima; Koji Izutsu
Journal:  Blood Adv       Date:  2020-09-22

Review 4.  KSHV/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states.

Authors:  Serge Alexanian; Jonathan Said; Mark Lones; Sheeja T Pullarkat
Journal:  Am J Surg Pathol       Date:  2013-02       Impact factor: 6.394

Review 5.  How do viruses trick B cells into becoming lymphomas?

Authors:  Ethel Cesarman
Journal:  Curr Opin Hematol       Date:  2014-07       Impact factor: 3.284

Review 6.  Pathology of lymphoma in HIV.

Authors:  Ethel Cesarman
Journal:  Curr Opin Oncol       Date:  2013-09       Impact factor: 3.645

Review 7.  Durable remission by sobuzoxane in an HIV-seronegative patient with human herpesvirus 8-negative primary effusion lymphoma.

Authors:  Yoriko Inoue; Kunihiro Tsukasaki; Kazuhiro Nagai; Hisashi Soda; Masao Tomonaga
Journal:  Int J Hematol       Date:  2004-04       Impact factor: 2.490

8.  Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis.

Authors:  Justin J Kuhlman; Muhamad Alhaj Moustafa; Alexander J Tun; David M Menke; Han W Tun; Liuyan Jiang
Journal:  Clin Case Rep       Date:  2021-04-04

9.  HHV8-Negative Primary Effusion Lymphoma of B-Cell Lineage: Two Cases and a Comprehensive Review of the Literature.

Authors:  Neeraj Saini; Ephraim P Hochberg; Erica A Linden; Smita Jha; Heinz K Grohs; Aliyah R Sohani
Journal:  Case Rep Oncol Med       Date:  2013-01-16

Review 10.  Primary Effusion Lymphoma: A Timely Review on the Association with HIV, HHV8, and EBV.

Authors:  Chih-Yi Liu; Bo-Jung Chen; Shih-Sung Chuang
Journal:  Diagnostics (Basel)       Date:  2022-03-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.